GlassScriptPhysician profile
Benjamin C Miles
NPI 1982733036
$933.13
in general payments reported to CMS, 2019-2025
18 companies · $226 in 2025
The $226 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.57 · 2021: $178 · 2022: $81.52 · 2023: $201 · 2024: $232 · 2025: $226.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $658.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $188.83 | 2019-2025 | |
| Ethicon US, LLC | $115.73 | 2021 | |
| Biogen, INC. | $84.73 | 2025 | Zurzuvae |
| Astellas Pharma US INC | $77.09 | 2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $65.38 | 2022-2023 | |
| Pfizer INC. | $48.01 | 2023-2024 | |
| Exact Sciences Corporation | $45.11 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Millicent US INC | $41.17 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Applied Medical Resources Corporation | $37.18 | 2021 | |
| Boston Scientific Corporation | $33.88 | 2024-2025 | General - Female Sui |
| Shield Therapeutics INC | $30.25 | 2024 | |
| Organon LLC | $26.90 | 2024-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $25.28 | 2021 | |
| Exeltis, USA INC. | $24.89 | 2025 | Slynd |
| Sumitomo Pharma America, INC. | $23.94 | 2024 | Gemtesa |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $23.68 | 2022 | |
| Glaxosmithkline, LLC. | $22.44 | 2022 | |
| Cardiva Medical, INC. | $18.64 | 2023 | Cardiva Vascade 6/7f Vcs |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Miles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.